4DMedical secures regulatory approval for CTVQ in Canada
Filed with ASX · · 3 pages · English
Melbourne, Australia, 15 December 2025: 4DMedical Limited (ASX: 4DX, “4DMedical” or the “Company”) a global leader in respiratory imaging technology, today announces Canadian regulatory approval for CT:VQ™, the world's first and only non-contrast, CT-based ventilation-perfusion imaging solution. This approval marks a significant expansion of 4DMedical's presence in North America, enabling immediat
Story so far
Earlier from 4DMedical
- 4DMedical secures $30.2 million with options underwrite
- University of Miami adopts CTVQ
- 4DMedical secures US$10m CTVQ orders in Philips deal
- CTVQ commercial rollout commences at Stanford
- 4DMedical secures $22.6 million via exercise of options
Later from 4DMedical
- Cleveland Clinic adopts CTVQ
- UC San Diego Health adopts CTVQ
- Trading Halt
- 4DMedical completes $150 million institutional placement
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical